Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

GLOBAL MARKETS-Stocks rally as investors pin hopes on coronavirus treatment

Published 2020-08-24, 02:21 a/m
© Reuters.
EUR/USD
-
GBP/USD
-
USD/JPY
-
UK100
-
XAU/USD
-
DE40
-
STOXX50
-
JP225
-
JPM
-
DE30
-
DX
-
GC
-
LCO
-
UK100
-
ESU24
-
CL
-
EU50
-
KS11
-
MIAPJ0000PUS
-
CSI300
-

* Asian stock markets : https://tmsnrt.rs/2zpUAr4

* Asian shares rise for 2nd straight day; China, Japan climb

* E-Mini futures for S&P500 gain 0.4%

* Coronavirus treatment, vaccine hopes support sentiment

* Oil prices rise, gold falters

By Swati Pandey

SYDNEY, Aug 24 (Reuters) - Asian shares advanced for a second straight session on Monday, underpinned by coronavirus hopes after U.S. regulators authorised the use of blood plasma from recovered patients as a treatment option.

The announcement from the U.S. Food & Drug Administration of a so-called "emergency use authorisation" came on the eve of the Republican National Convention, where Donald Trump will be nominated to lead his party for four more years. futures for the S&P500 ESc1 gained 0.4%. European markets were also set for a leg higher with futures for Euro Stoxx 50 STXEc1 up 0.65% while those for Germany's DAX FDXc1 and London's FTSE FFIc1 added 0.6% each.

MSCI's broadest index of Asia-Pacific shares outside of Japan .MIAPJ0000PUS jumped 0.8%, edging closer to a six-month high touched last week.

Japan's Nikkei .N225 reversed early losses to be last up 0.3%. Chinese shares rose too with the blue-chip CSI 300 index .CSI300 adding 0.8%.

South Korea's KOSPI .KS11 , which has been on a slippery slope since hitting a more than two-year peak earlier this month, climbed 1%.

"Whenever there is any news that is seen as something that is helping the battle against coronavirus it gives a boost to sentiment," said Shane Oliver, Sydney-based chief economist at AMP.

"It's just hard to tell whether this will be a game changer. We still don't know if it's going to work," he added, referring to the plasma treatment.

Equity market sentiment was also supported by a Financial Times report that the Trump administration is considering by-passing normal U.S. regulatory standards to fast-track an experimental coronavirus vaccine from the UK for use in America ahead of the presidential election.

Analysts urged caution with Wall Street indexes already at record highs even as the world economy struggled to recover from the once-in-a-century pandemic.

"With risks rising somewhat and September a full month for policy, the end of summer is a good time to cross-check valuations and to consider both threats and opportunities," said JPMorgan (NYSE:JPM) cross asset analyst John Normand.

Normand pointed to talks of a U.S. fiscal package, Fed's upcoming policy review next month and the ramping up of the U.S. election campaign as risk events over coming weeks.

Adding a layer of complication on Trump's re-election campaign, White House adviser Kellyanne Conway on Sunday said she would leave the administration at the end of this month, leaving the president without one of his more passionate spokespersons. large over this week was a keenly anticipated address by Federal Reserve Chair Jerome Powell at the Kansas City Fed Jackson Hole symposium, where he will talk on the Fed's monetary policy framework review.

"This takes on even more significance after the market's evident disappointment last week," said Ray Attrill, head of forex strategy at Melbourne-based National Australia Bank.

The Fed's July meeting minutes last week barely made a mention of its policy outlook while "failing to give succour to expectations" that its September meeting would reveal a formal commitment to new outcome-based' forward guidance, Attrill added.

In currencies, the dollar was a shade weaker on the safe haven Japanese yen JPY= at 105.83.

The British pound GBP= nursed losses after falling 0.9% on Friday on lack of progress in post-Brexit trade talks with the European Union. It was last up a shade at $1.3100. euro EUR= was defensive at $1.1800 after falling 0.5% on Friday following disappointing manufacturing activity data.

That left the dollar index slightly lower at 93.193.

In commodities, oil prices rose on Monday, with Brent crude LCOc1 up 8 cents at $44.43 a barrel and U.S. crude CLc1 climbing 7 cents to $42.37. O/R

Gold saw some selling pressure with spot prices XAU= off 0.3% at $1,932.89 an ounce.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Asia stock markets

https://tmsnrt.rs/2zpUAr4 Asia-Pacific valuations

https://tmsnrt.rs/2Dr2BQA

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.